Navidea Biopharmaceuticals (NAVB)

Navidea (NAVB) Income Statement


Navidea Income Statement

Last quarter (Q2 2023), Navidea's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q2, Navidea's net income was $5.82M. See Navidea’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 8.13K$ -132.00K$ 45.62K$ 118.72K$ 657.83K$ 1.17M
Cost of Revenue
$ -36.00$ 1.94K$ 0.00$ 1.05K$ 6.67K$ 96.64K
Gross Profit
$ -176.35K$ -133.94K$ 45.62K$ 117.68K$ 651.16K$ 1.07M
Operating Expense
$ 1.68M$ 13.93M$ 12.11M$ 10.83M$ 11.61M$ 11.92M
Operating Income
$ -8.16M$ -14.07M$ -12.06M$ -10.71M$ -10.96M$ -10.85M
Net Non Operating Interest Income Expense
$ -1.43M$ -1.10M$ -6.36K$ 11.34K$ 25.29K$ -30.80K
Other Income Expense
$ 392.23K$ 13.29K$ 351.88K$ -21.85K$ -7.61K$ -5.29M
Pretax Income
$ -8.44M$ -15.18M$ -11.71M$ -10.72M$ -10.94M$ -16.17M
Tax Provision
$ -413.25K$ -413.25K$ 16.04K$ 0.00$ 707.00$ -9.75K
Earnings From Equity Interest Net Of Tax
Net Income Common Stockholders
$ -2.04M$ -17.22M$ -11.73M$ -11.39M$ -10.95M$ -16.11M
Basic EPS
$ -0.17$ -0.56$ -0.40$ -0.48$ -0.76$ -1.89
Diluted EPS
$ -0.06$ -0.56$ -0.40$ -0.48$ -0.76$ -1.89
Basic Average Shares
$ 142.53M$ 30.90M$ 29.34M$ 23.90M$ 14.39M$ 8.53M
Diluted Average Shares
$ 111.63M$ 30.90M$ 29.34M$ 23.90M$ 14.39M$ 8.53M
Dividend Per Share
Total Operating Income As Reported
Reported Normalized Basic E P S
Reported Normalized Diluted E P S
Rent Expense Supplemental
Total Expenses
$ 1.68M$ 13.93M$ 12.11M$ 10.83M$ 11.62M$ 12.02M
Net Income From Continuing And Discontinued Operation
$ -4.84M$ -15.18M$ -11.73M$ -10.72M$ -10.95M$ -16.11M
Normalized Income
$ -6.81M-$ -12.00M$ -10.72M$ -10.95M$ -10.87M
Interest Expense
--$ 6.36K---
$ -7.02M$ -15.66M$ -11.71M$ -10.71M$ -10.96M$ -10.85M
$ -6.93M$ -15.25M$ -11.63M$ -10.64M$ -10.82M$ -10.70M
Currency in USD

Navidea Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis